Overview
Grayson-Wilbrandt corneal dystrophy is a very rare eye condition that affects the cornea, which is the clear, dome-shaped front surface of the eye. In this dystrophy, abnormal deposits form in a specific layer of the cornea called Bowman's layer, which sits just beneath the outer surface (epithelium) of the cornea. These deposits can cause the cornea to become cloudy or irregular, which may lead to changes in vision over time. People with Grayson-Wilbrandt corneal dystrophy typically notice blurred vision or visual disturbances that develop gradually. The condition may also cause episodes of eye pain or discomfort, particularly if the surface of the cornea is affected. Some patients experience recurrent corneal erosions, which are painful episodes where the outer layer of the cornea breaks down. This condition is classified under the broader group of corneal dystrophies, specifically those affecting Bowman's layer. Because it is extremely rare, there is limited information about its full clinical spectrum. Treatment is generally focused on managing symptoms. Mild cases may be treated with lubricating eye drops and ointments, while more severe cases that significantly impair vision may require surgical interventions such as phototherapeutic keratectomy (a laser procedure to smooth the corneal surface) or, in advanced cases, corneal transplantation. Regular follow-up with an eye specialist is important to monitor progression.
Also known as:
Key symptoms:
Blurred or hazy visionCloudy patches on the front of the eyeRecurrent eye pain or discomfortRecurrent corneal erosions (painful breakdown of the eye surface)Sensitivity to lightTearing or watery eyesFeeling of something in the eye (foreign body sensation)Gradual worsening of vision over timeIrregular corneal surface
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Grayson-Wilbrandt corneal dystrophy.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Grayson-Wilbrandt corneal dystrophy at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Grayson-Wilbrandt corneal dystrophy.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Grayson-Wilbrandt corneal dystrophy.
Community
No community posts yet. Be the first to share your experience with Grayson-Wilbrandt corneal dystrophy.
Start the conversation →Latest news about Grayson-Wilbrandt corneal dystrophy
No recent news articles for Grayson-Wilbrandt corneal dystrophy.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.How severe is the corneal dystrophy in my case, and how much is it affecting my vision?,How quickly is this condition likely to progress?,What can I do to prevent or reduce recurrent corneal erosion episodes?,Would phototherapeutic keratectomy (PTK) be a good option for me?,At what point would a corneal transplant be recommended?,Should my family members be examined for this condition?,Is genetic testing recommended for me or my family?
Common questions about Grayson-Wilbrandt corneal dystrophy
What is Grayson-Wilbrandt corneal dystrophy?
Grayson-Wilbrandt corneal dystrophy is a very rare eye condition that affects the cornea, which is the clear, dome-shaped front surface of the eye. In this dystrophy, abnormal deposits form in a specific layer of the cornea called Bowman's layer, which sits just beneath the outer surface (epithelium) of the cornea. These deposits can cause the cornea to become cloudy or irregular, which may lead to changes in vision over time. People with Grayson-Wilbrandt corneal dystrophy typically notice blurred vision or visual disturbances that develop gradually. The condition may also cause episodes of
How is Grayson-Wilbrandt corneal dystrophy inherited?
Grayson-Wilbrandt corneal dystrophy follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.